| 1 | = | Malignant Prostate Neoplasm | 266,307 | 100 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 8359
- siteDefinition
- USCS "Prostate" (ICD-10 C61; ICD-O-3 C619)
ranking row 2608485 |
| 2 | = | Malignant Lung Neoplasm | 112,183 | 96.2 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3819
- siteDefinition
- USCS "Lung and Bronchus" (ICD-10 C34; ICD-O-3 C340-C349)
ranking row 2608486 |
| 3 | = | Malignant Bladder Neoplasm | 61,094 | 92.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7389
- siteDefinition
- USCS "Urinary Bladder" (ICD-10 C67; ICD-O-3 C670-C679)
ranking row 2608487 |
| 4 | = | Cutaneous Melanoma | 60,747 | 88.5 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4125
- siteDefinition
- USCS "Melanomas of the Skin" (ICD-10 C43; ICD-O-3 C440-C449 with histology 8720-8790)
ranking row 2608488 |
| 5 | = | Malignant Colon Neoplasm | 55,172 | 84.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 915
- siteDefinition
- USCS "Colon excluding Rectum" (ICD-10 C18, C26.0; ICD-O-3 C180-C189, C260)
ranking row 2608489 |
| 6 | = | Malignant Kidney Neoplasm | 49,629 | 80.8 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2595
- siteDefinition
- USCS "Kidney and Renal Pelvis" (ICD-10 C64-C65; ICD-O-3 C649, C659)
ranking row 2608490 |
| 7 | = | Non-Hodgkin Lymphoma | 42,101 | 76.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5349
- siteDefinition
- USCS "Non-Hodgkin Lymphoma" (ICD-10 C82-C85, C96.3; ICD-O-3 histology 9590-9597, 9670-9729, 9735, 9737-9738 (+9811-9818, 9823, 9827, 9837 outside marrow/blood))
ranking row 2608491 |
| 8 | = | Leukemia | 34,124 | 73.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3207
- siteDefinition
- USCS "Leukemias" (ICD-10 C91-C95 (leukemia recodes; C90.1 plasma cell leukemia included by SEER); ICD-O-3 leukemia histologies 9733-9948 per SEER site recode)
ranking row 2608492 |
| 9 | = | Malignant Pancreatic Neoplasm | 31,929 | 69.2 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5859
- siteDefinition
- USCS "Pancreas" (ICD-10 C25; ICD-O-3 C250-C259)
ranking row 2608493 |
| 10 | = | Malignant Rectal Neoplasm | 27,779 | 65.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6165
- siteDefinition
- USCS "Rectum and Rectosigmoid Junction" (ICD-10 C19-C20; ICD-O-3 C199, C209)
ranking row 2608494 |
| 11 | = | Malignant Liver Neoplasm | 26,463 | 61.5 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3513
- siteDefinition
- USCS "Liver and Intrahepatic Bile Duct" (ICD-10 C22; ICD-O-3 C220-C221)
ranking row 2608495 |
| 12 | = | Multiple Myeloma | 18,162 | 57.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4737
- siteDefinition
- USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734)
ranking row 2608496 |
| 13 | = | Malignant Gastric Neoplasm | 17,327 | 53.8 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6777
- siteDefinition
- USCS "Stomach" (ICD-10 C16; ICD-O-3 C160-C169)
ranking row 2608497 |
| 14 | = | Malignant Esophageal Neoplasm | 15,687 | 50 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1425
- siteDefinition
- USCS "Esophagus" (ICD-10 C15; ICD-O-3 C150-C159)
ranking row 2608498 |
| 15 | = | Malignant Thyroid Gland Neoplasm | 13,779 | 46.2 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7083
- siteDefinition
- USCS "Thyroid" (ICD-10 C73; ICD-O-3 C739)
ranking row 2608499 |
| 16 | = | Malignant Central Nervous System Neoplasm | 12,717 | 42.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 405
- siteDefinition
- USCS "Brain and Other Nervous System" (ICD-10 C70, C71, C72; ICD-O-3 C700-C709, C710-C719, C720-C729)
ranking row 2608500 |
| 17 | = | Malignant Testicular Neoplasm | 9,572 | 38.5 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 8563
- siteDefinition
- USCS "Testis" (ICD-10 C62; ICD-O-3 C620-C629)
ranking row 2608501 |
| 18 | = | Malignant Laryngeal Neoplasm | 9,409 | 34.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2901
- siteDefinition
- USCS "Larynx" (ICD-10 C32; ICD-O-3 C320-C329)
ranking row 2608502 |
| 19 | = | Hodgkin Lymphoma | 4,966 | 30.8 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1833
- siteDefinition
- USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal))
ranking row 2608503 |
| 20 | = | Malignant Salivary Gland Neoplasm | 3,065 | 26.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6471
- siteDefinition
- USCS "Salivary Gland" (ICD-10 C07-C08; ICD-O-3 C079-C089)
ranking row 2608504 |
| 21 | = | Malignant Anal Neoplasm | 3,059 | 23.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 99
- siteDefinition
- USCS "Anus, Anal Canal and Anorectum" (ICD-10 C21; ICD-O-3 C210-C212, C218)
ranking row 2608505 |
| 22 | = | Malignant Breast Neoplasm | 2,563 | 19.2 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 8053
- siteDefinition
- USCS "Male Breast" (ICD-10 C50; ICD-O-3 C500-C509)
ranking row 2608506 |
| 23 | = | Malignant Mesothelioma | 1,926 | 15.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4431
- siteDefinition
- USCS "Mesothelioma" (ICD-10 C45; ICD-O-3 histology 9050-9055 (any site))
ranking row 2608507 |
| 24 | = | Malignant Hypopharyngeal Neoplasm | 1,660 | 11.5 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2139
- siteDefinition
- USCS "Hypopharynx" (ICD-10 C12-C13; ICD-O-3 C129, C130-C139)
ranking row 2608508 |
| 25 | = | Malignant Penile Neoplasm | 1,599 | 7.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 8155
- siteDefinition
- USCS "Penis" (ICD-10 C60; ICD-O-3 C600-C609)
ranking row 2608509 |
| 26 | = | Malignant Nasopharyngeal Neoplasm | 1,321 | 3.8 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5043
- siteDefinition
- USCS "Nasopharynx" (ICD-10 C11; ICD-O-3 C110-C119)
ranking row 2608510 |
| 27 | = | Kaposi Sarcoma | 990 | 0 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2445
- siteDefinition
- USCS "Kaposi Sarcoma" (ICD-10 C46; ICD-O-3 histology 9140 (any site))
ranking row 2608511 |